Last updated: March 29, 2026

Opioids bind to opiate receptors (mu, kappa, and delta), which are involved in analgesia, sedation, and dependence. They are commonly administered intravenously (appear as needle marks forming a track on physical exam) or inhaled (increasingly smoked with cannabis nowadays). Most patients with acute intoxication will present with coma/death, since different formulations with different concentrations exist. For patients abusing prescription opioids, behaviors such as losing medication, consulting multiple doctors, and running out of medication early should raise the alarm for possible misuse.

Commonly used opioids

OpioidsExamples
PrescriptionOxycodone (OxyContin), Vicodin (hydrocodone/acetaminophen), Percocet (oxycodone/acetaminophen)
Non-prescriptionHeroin
  • Signs and symptoms of intoxication
    • Drowsiness
    • Nausea and vomiting
    • Constipation
    • Slurred speech
    • Constricted pupils
    • Seizures
    • Respiratory depression → coma/death
  • Signs and symptoms of withdrawal
    • Dysphoria
    • Insomnia
    • Lacrimation
    • Rhinorrhea
    • Yawning
    • Weakness
    • Sweating
    • Piloerection
    • Nausea/vomiting
    • Fever
    • Dilated pupils
    • Abdominal cramps
    • Arthralgia and myalgia
    • Hypertension
    • Tachycardia
    • Craving
  • Treatment of acute intoxication
    • ABCs
    • Naloxone to reverse respiratory depression (may cause severe withdrawal in an opioid dependent patient)
    • Admission to the ICU for ventilatory support may be needed
  • Treatment of withdrawal
    • Monitor the degree of withdrawal using the Clinical Opioid Withdrawal Scale (COWS)
    • Clonidine: for in-patient symptomatic treatment (autonomic signs and symptoms)
    • NSAIDs: symptomatic treatment (pain)
    • Dicyclomine: symptomatic treatment (abdominal cramps)
    • Detoxification with buprenorphine or methadone for severe symptoms
  • Methadone for opioid use disorder
    • Initial doses of 15-30mg are used.
    • Then increased by 10-15mg every 3-5 days until 50-80mg is reached.
    • Doses are then increased gradually as tolerated and cravings decrease.
    • Typical effective dose is 80-100mg.
    • For a patient in withdrawal: if the patient is in a methadone program, start 10mg below the current level. If not, start at 10-30mg, whatever dose cures withdrawal symptoms. Continue the dose for 7-14 days. Then decrease the dose by 10-20% every 1-2 days over 2-3 weeks.
  • Buprenorphine for opioid use disorder
    • It is typically started at 4-8mg on day 1.
    • On day 2, the dose is increased to up to 16mg.
    • During the 1st week, the dose can be increased daily to a dose of about 32 mg.
    • Most patients are stabilized on 16-24mg. Withdrawal symptoms are absent, opioid misuse is diminished or absent, and cravings are minimized.
    • For a patient in withdrawal: Initiate 12-48 hours after the last use of opiate when in early withdrawal at 4-8 mg. May be increased to 16mg if the patient is not responding. Continue the dose for 2-5 days. Then taper for 10-20% Q1-2 days over 2 or more weeks.

Methadone vs buprenorphine vs naltrexone for Opioid Use Disorder

DrugMethadoneBuprenorphineNaltrexone
MechanismLong-acting opioid receptor agonistPartial opioid receptor agonistCompetitive opioid antagonist (precipitates withdrawal if used within 7 days of heroin use)
AdvantagesOnce daily dosing, higher retention, and cheaper than buprenorphineSublingual ROA is safer and makes overdose unlikely. Can be combined with naloxone (as suboxone), which prevents intoxication from intravenous injectionOnce daily dosing or monthly depot (long-acting injection). Good choice for highly motivated patients
DisadvantagesCan cause QTc prolongation (needs a screening EKG for patients at risk, hence the dose is limited to a maximum of 100mg)More expensive, less patient retention than methadoneMore difficult to achieve compliance

Reference Intervals
Biochemistry
ACTHP: <80 ng/L
ALTP: 5–35 U/L
AlbuminP: 35–50 g/L
AldosteroneP: 100–500 pmol/L
Alk. phosphataseP: 30–130 U/L
α-AmylaseP: 0–180 IU/dL
α-FetoproteinS: <10 kU/L
Angiotensin IIP: 5–35 pmol/L
ADHP: 0.9–4.6 pmol/L
ASTP: 5–35 U/L
BicarbonateP: 24–30 mmol/L
BilirubinP: 3–17 μmol/L
BNPP: <50 ng/L
CRPP: <10 mg/L
CalcitoninP: <0.1 mcg/L
Calcium (ionized)P: 1.0–1.25 mmol/L
Calcium (total)P: 2.12–2.60 mmol/L
ChlorideP: 95–105 mmol/L
CholesterolP: <5.0 mmol/L
VLDLP: 0.128–0.645 mmol/L
LDLP: <2.0 mmol/L
HDLP: 0.9–1.93 mmol/L
Cortisol AMP: 450–700 nmol/L
Cortisol MidnightP: 80–280 nmol/L
CK ♂P: 25–195 U/L
CK ♀P: 25–170 U/L
CreatinineP: 70–100 μmol/L
FerritinP: 12–200 mcg/L
FolateS: 2.1 mcg/L
FSHP: 2–8 U/L ♂; >25 menopause
GGT ♂P: 11–51 U/L
GGT ♀P: 7–33 U/L
Glucose (fasting)P: 3.5–5.5 mmol/L
Growth hormoneP: <20 mu/L
HbA1C (DCCT)B: 4–6%
HbA1C (IFCC)B: 20–42 mmol/mol
Iron ♂S: 14–31 μmol/L
Iron ♀S: 11–30 μmol/L
Lactate (venous)P: 0.6–2.4 mmol/L
Lactate (arterial)P: 0.6–1.8 mmol/L
LDHP: 70–250 U/L
LHP: 3–16 U/L
MagnesiumP: 0.75–1.05 mmol/L
OsmolalityP: 278–305 mosmol/kg
PTHP: 0.8–8.5 pmol/L
PotassiumP: 3.5–5.3 mmol/L
Prolactin ♂P: <450 U/L
Prolactin ♀P: <600 U/L
PSAP: 0–4 mcg/mL
Protein (total)P: 60–80 g/L
Red cell folateB: 0.36–1.44 μmol/L
Renin (erect)P: 2.8–4.5 pmol/mL/h
Renin (recumbent)P: 1.1–2.7 pmol/mL/h
SodiumP: 135–145 mmol/L
TBGP: 7–17 mg/L
TSHP: 0.5–4.2 mU/L
T4P: 70–140 nmol/L
Free T4P: 9–22 pmol/L
TIBCS: 54–75 μmol/L
TriglyceridesP: 0.50–2.3 mmol/L
T3P: 1.2–3.0 nmol/L
Troponin TP: <0.1 mcg/L
Urate ♂P: 210–480 μmol/L
Urate ♀P: 150–390 μmol/L
UreaP: 2.5–6.7 mmol/L
Vitamin B12S: 0.13–0.68 nmol/L
Vitamin DS: 50 nmol/L
Arterial Blood Gases
pH7.35–7.45
PaCO₂4.7–6.0 kPa
PaO₂>10.6 kPa
Base excess±2 mmol/L
Urine
Cortisol (free)<280 nmol/24h
Hydroxyindole acetic acid16–73 μmol/24h
Hydroxymethylmandelic acid16–48 μmol/24h
Metanephrines0.03–0.69 μmol/mmol cr.
Osmolality350–1000 mosmol/kg
17-Oxogenic steroids ♂28–30 μmol/24h
17-Oxogenic steroids ♀21–66 μmol/24h
17-Oxosteroids ♂17–76 μmol/24h
17-Oxosteroids ♀14–59 μmol/24h
Phosphate (inorganic)15–50 mmol/24h
Potassium14–120 mmol/24h
Protein<150 mg/24h
Protein/creatinine ratio<3 mg/mmol
Sodium100–250 mmol/24h
Haematology
WCC4.0–11.0 ×10⁹/L
RBC ♂4.5–6.5 ×10¹²/L
RBC ♀3.9–5.6 ×10¹²/L
Hb ♂130–180 g/L
Hb ♀115–160 g/L
PCV ♂0.4–0.54 L/L
PCV ♀0.37–0.47 L/L
MCV76–96 fL
MCH27–32 pg
MCHC300–360 g/L
RDW11.6–14.6%
Neutrophils2.0–7.5 ×10⁹/L (40–75%)
Lymphocytes1.0–4.5 ×10⁹/L (20–45%)
Eosinophils0.04–0.44 ×10⁹/L (1–6%)
Basophils0–0.10 ×10⁹/L (0–1%)
Monocytes0.2–0.8 ×10⁹/L (2–10%)
Platelets150–400 ×10⁹/L
Reticulocytes0.8–2.0% / 25–100 ×10⁹/L
Prothrombin time10–14 s
APTT35–45 s
Paediatric
Pulse Rate (bpm)
Neonate140–160
Infant <1yr120–140
1–5 years110–130
5–12 years80–120
>12 years70–100
Respiratory Rate (tachypnoea)
0–2 months≥60/min
2–12 months≥50/min
1–5 years≥40/min
>5 years≥30/min
Blood Pressure (mmHg)
Term65/45
1 year75/50
4 years85/60
8 years95/65
10 years100/70
Weight Formulas
3–12 months(a + 9)/2 kg
1–6 years2a + 8 kg
>6 years(7a − 5)/2 kg
Haemoglobin (g/dL)
Term newborn13–20
1 month11–18
2 months10–15
1–2 years10–13
>2 years11–14
MUAC (6 months–5 years)
Obese>17.5 cm
Normal13.5–17.4 cm
At risk12.5–13.4 cm
Moderate malnutrition11.5–12.4 cm
Severe malnutrition<11.5 cm
Developmental Milestones
Social smile1.5 months
Head control4 months
Sits unsupported7 months
Crawls10 months
Stands unsupported10–12 months
Walks12–13 months
Talks18 months
CSF WBC (/mm³)
Term newborn0–25
>2 weeks0–5
Calculator

Post Discussion

Your email address will not be published. Required fields are marked *